Shay Capital’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
Other funds holding VINC
SRC
DM
RCMNY
TCM
AAA
RSCM
RI
SFM
Shay Capital's VINC Position: Q3 2021 in Review
Shay Capital sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2021, closing a stake of 568 shares — an estimated $148K sold.
Shay Capital first reported a position in VINC in Q2 2021 and held it in 1 quarter. The position peaked at $148K in Q2 2021. 56 funds tracked by Wall St. Rank hold VINC as of Q3 2021.
- Shay Capital reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Shay Capital sold 568 Vincerx Pharma, Inc. Common Stock shares in Q3 2021, an estimated $148K.
- Shay Capital first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
- Shay Capital's Vincerx Pharma, Inc. Common Stock position peaked at $148K in Q2 2021.
- 56 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2021.
Based on Shay Capital's 13F filing for Q3 2021, filed 15 Nov 2021.